Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
- PMID: 37132142
- PMCID: PMC10845104
- DOI: 10.2174/1570159X21666230428091433
Treatment of Posttraumatic Stress Disorder: A State-of-the-art Review
Abstract
This narrative state-of-the-art review paper describes the progress in the understanding and treatment of Posttraumatic Stress Disorder (PTSD). Over the last four decades, the scientific landscape has matured, with many interdisciplinary contributions to understanding its diagnosis, etiology, and epidemiology. Advances in genetics, neurobiology, stress pathophysiology, and brain imaging have made it apparent that chronic PTSD is a systemic disorder with high allostatic load. The current state of PTSD treatment includes a wide variety of pharmacological and psychotherapeutic approaches, of which many are evidence-based. However, the myriad challenges inherent in the disorder, such as individual and systemic barriers to good treatment outcome, comorbidity, emotional dysregulation, suicidality, dissociation, substance use, and trauma-related guilt and shame, often render treatment response suboptimal. These challenges are discussed as drivers for emerging novel treatment approaches, including early interventions in the Golden Hours, pharmacological and psychotherapeutic interventions, medication augmentation interventions, the use of psychedelics, as well as interventions targeting the brain and nervous system. All of this aims to improve symptom relief and clinical outcomes. Finally, a phase orientation to treatment is recognized as a tool to strategize treatment of the disorder, and position interventions in step with the progression of the pathophysiology. Revisions to guidelines and systems of care will be needed to incorporate innovative treatments as evidence emerges and they become mainstream. This generation is well-positioned to address the devastating and often chronic disabling impact of traumatic stress events through holistic, cutting-edge clinical efforts and interdisciplinary research.
Keywords: Posttraumatic stress disorder; intervention; ketamine; moral injury; neuromodulation.; psychedelic; psychotherapy; psychotropic drugs.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Conflict of interest statement
The authors declare no conflict of interest, financial or otherwise.
Similar articles
-
[Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].Encephale. 2012 Oct;38(5):373-80. doi: 10.1016/j.encep.2011.12.003. Epub 2012 Jan 24. Encephale. 2012. PMID: 23062450 Review. French.
-
Pharmacotherapy for posttraumatic stress disorder.Cochrane Database Syst Rev. 2000;(4):CD002795. doi: 10.1002/14651858.CD002795. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002795. doi: 10.1002/14651858.CD002795.pub2. PMID: 11034765 Updated. Review.
-
Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review.Health Technol Assess. 2020 Sep;24(43):1-312. doi: 10.3310/hta24430. Health Technol Assess. 2020. PMID: 32924926 Free PMC article.
-
Reviewing the Potential of Psychedelics for the Treatment of PTSD.Int J Neuropsychopharmacol. 2020 Jun 24;23(6):385-400. doi: 10.1093/ijnp/pyaa018. Int J Neuropsychopharmacol. 2020. PMID: 32170326 Free PMC article. Review.
-
Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.PLoS Med. 2020 Aug 19;17(8):e1003262. doi: 10.1371/journal.pmed.1003262. eCollection 2020 Aug. PLoS Med. 2020. PMID: 32813696 Free PMC article.
Cited by
-
Alterations in brain network connectivity and subjective experience induced by psychedelics: a scoping review.Front Psychiatry. 2024 May 14;15:1386321. doi: 10.3389/fpsyt.2024.1386321. eCollection 2024. Front Psychiatry. 2024. PMID: 38807690 Free PMC article. Review.
-
Three Prospective Case Studies Examining Mifepristone's Efficacy in Patients with Treatment-Resistant PTSD.Case Rep Psychiatry. 2024 Apr 26;2024:4768647. doi: 10.1155/2024/4768647. eCollection 2024. Case Rep Psychiatry. 2024. PMID: 38706512 Free PMC article.
-
Neuronal population representation of human emotional memory.Cell Rep. 2024 Apr 23;43(4):114071. doi: 10.1016/j.celrep.2024.114071. Epub 2024 Apr 8. Cell Rep. 2024. PMID: 38592973 Free PMC article.
-
Exploring Care and Recovery for Individuals With Post-traumatic Stress Disorder: A Scoping Review.Cureus. 2024 Feb 6;16(2):e53741. doi: 10.7759/cureus.53741. eCollection 2024 Feb. Cureus. 2024. PMID: 38465133 Free PMC article. Review.
-
Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries.Eur Psychiatry. 2024 Mar 7;67(1):e24. doi: 10.1192/j.eurpsy.2024.19. Eur Psychiatry. 2024. PMID: 38450651 Free PMC article. Review.
References
-
- Vermetten E., Lanius R.A. Biological and clinical framework for posttraumatic stress disorder. In: Aminoff MJ., Boller F., Swaab DF, editors. Handbook of Clinical Neurology. pp. 291–342. - PubMed
-
- Kessler R.C. Posttraumatic stress disorder: The burden to the individual and to society. J. Clin. Psychiatry. 2000;61(Suppl. 5):4–12. - PubMed